Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Andres Alvarisqueta et al.|The Lancet|2019Cited by 609
Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic controlUrsula Barnas, Gert Mayer, Alice Schmidt et al.|Diabetologia|1997Cited by 65
Parameters associated with chronic renal transplant failure.Ursula Barnas, Gert Mayer, Alice Schmidt et al.|PubMed|1997Cited by 40
The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failureUrsula Barnas, Gert Mayer, Alice Schmidt et al.|Nephrology Dialysis Transplantation|1996Cited by 31
Angiotensin-converting enzyme polymorphism in patients with terminal renal failure.Alice Schmidt, Gert Mayer, H. Kiener et al.|Journal of the American Society of Nephrology|1996Cited by 31